Reduced 5‐HT1A receptor binding in the medial prefrontal cortex and hippocampus contributes to MDD pathophysiology, while genetic variation predicts SSRI treatment response (Kishi et al. The gene discussed is HTR1A; the disease is major depressive disorder.